Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5204 participants.
Also called NCT07478003
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 5,204 participants
- Registry
-
NCT07478003
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT07478003. Randomized; quadruple masking; primary purpose treatment. Start 2026-04-20 (actual); primary completion 2031-04-20 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
- Acronym
- PULSE-MI 2
- Condition
- STEMI - ST Elevation Myocardial Infarction
- Intervention (Drug)
- Methylprednisolone 250 mg
- Intervention (Drug)
- NaCl (0,9%)
- Lead sponsor
- Thomas Engstrom
- Collaborator
- Aarhus University Hospital
- Collaborator
- Odense University Hospital
- Collaborator
- Aalborg University Hospital
- Collaborator
- Prehospital Emergency Medical Service, The North Denmark Region
- Collaborator
- Center for Prehospital and Emergency Research, Denmark
- Collaborator
- Prehospital Center, Region Zealand
- Collaborator
- Prehospital Emergency Medical Services Central Denmark Region (Præhospitalet)
Record details
- Record id
cardio:ct-nct07478003- Content hash
b5ce1d6f2fac1f7cd8ddb1e4cddfb2e372ec6694a8c78606c5e1286b0ca62720